These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association. Musunuru K; Sheikh F; Gupta RM; Houser SR; Maher KO; Milan DJ; Terzic A; Wu JC; Circ Genom Precis Med; 2018 Jan; 11(1):e000043. PubMed ID: 29874173 [TBL] [Abstract][Full Text] [Related]
33. Thinking outside the liver: induced pluripotent stem cells for hepatic applications. Subba Rao M; Sasikala M; Nageshwar Reddy D World J Gastroenterol; 2013 Jun; 19(22):3385-96. PubMed ID: 23801830 [TBL] [Abstract][Full Text] [Related]
34. Experimental approaches for the generation of induced pluripotent stem cells. Sommer CA; Mostoslavsky G Stem Cell Res Ther; 2010 Aug; 1(3):26. PubMed ID: 20699015 [TBL] [Abstract][Full Text] [Related]
35. Generation and characterization of integration-free induced pluripotent stem cells from patients with autoimmune disease. Son MY; Lee MO; Jeon H; Seol B; Kim JH; Chang JS; Cho YS Exp Mol Med; 2016 May; 48(5):e232. PubMed ID: 27174201 [TBL] [Abstract][Full Text] [Related]
36. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system. Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575 [TBL] [Abstract][Full Text] [Related]
37. Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons. Sundberg M; Bogetofte H; Lawson T; Jansson J; Smith G; Astradsson A; Moore M; Osborn T; Cooper O; Spealman R; Hallett P; Isacson O Stem Cells; 2013 Aug; 31(8):1548-62. PubMed ID: 23666606 [TBL] [Abstract][Full Text] [Related]
38. Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy. Corti S; Nizzardo M; Simone C; Falcone M; Nardini M; Ronchi D; Donadoni C; Salani S; Riboldi G; Magri F; Menozzi G; Bonaglia C; Rizzo F; Bresolin N; Comi GP Sci Transl Med; 2012 Dec; 4(165):165ra162. PubMed ID: 23253609 [TBL] [Abstract][Full Text] [Related]
39. Induced pluripotent stem cells and their implication for regenerative medicine. Csobonyeiova M; Polak S; Koller J; Danisovic L Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593 [TBL] [Abstract][Full Text] [Related]
40. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications. Das AK; Pal R J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]